Study selection process
Our systematic search identified 12,370 articles across ScienceDirect, Scopus, and PubMed. An additional 5 records were obtained through other sources, resulting in a total of 12,375 articles. After removing duplicates, 10,089 unique records remained and were screened by title and abstract. Of these, 313 full-text articles were assessed for eligibility, and 120 studies were included in the systematic review [1, 2, 4, 5, 7–11, 13–123]. The study selection process is detailed in Fig. 1.
Included studies characteristics:
Of the 120 studies included in this review, the majority were categorized as therapeutic studies (72/120, or 60%). Surgical studies accounted for 34% (41/120), while diagnostic and sports medicine studies contributed 2% and 4%, respectively. All of the included studies were published between 2000 and 2025.
Table 1 summarizes the studies that employed pneumatic compression systems for therapeutic purposes. Three major types of devices were identified: intermittent pneumatic compression (IPC) device, sequential compression device (SCD), and external enhanced counter pulsation (EECP) system. IPC devices were used in 58% of the studies, while SCDs were used in 19%. EECP therapy was administered in 11 studies. Notably, five studies incorporated both IPC and SCD devices. These compression therapies were applied to manage a range of clinical conditions, including venous thromboembolism (VTE), deep vein thrombosis (DVT), lymphedema, and PAD. The diversity of applications highlights the clinical versatility of pneumatic compression systems. Table 2 presents the characteristics of surgical studies, all of which employed pneumatic tourniquet systems. These studies detail device settings, such as fixed or patient-specific cuff pressure based on systolic blood pressure (SBP) / limb occlusion pressure (LOP) and total tourniquet time, typically used in procedures such as orthopedic or vascular surgeries.
Table 3 details the diagnostic applications of pneumatic compression. Both studies in the diagnostic category employed compression cuffs to enhance vascular diagnostics: one study used pneumatic compression during magnetic resonance imaging (MRI) to assess venous outflow, while the other used it to measure arterial compliance via pulse waveform response. Device placement varied from the calf to the thigh, and pressures used were 50 mmHg and 200 mmHg. These studies demonstrated the feasibility of integrating pneumatic compression to facilitate physiological assessments and improve image clarity, despite their limited sample size. Table 4 presents five studies under the sports medicine category, all of which investigated blood flow restriction (BFR) therapy during exercise or recovery protocols. Devices were applied to the upper or lower limbs, and cuff pressures were commonly reported as a percentage of SBP or LOP, typically ranging from 40% to 130%. The duration of compression during exercise sessions ranged from 5 to 45 minutes. These studies aimed to improve muscular strength, vascular adaptation, or post-exercise recovery, highlighting the emerging interest in pneumatic compression for performance enhancement and rehabilitation in athletic and clinical populations. Only a few studies reported complications associated with pneumatic compression for therapeutic, surgical, and sports medicine purposes. The most common complications were pain, discomfort, wound, and skin damage along with a few other minor complications.
Table 1
Summary of included therapeutic studies using pneumatic compression systems
Study | Device type | Device location | Cuff pressure (mm Hg) | Inflation time (s) | Deflation time (s) | Complications | Therapeutic action |
|---|
Ahlbom et al. (2016) | EECP | Calves, thighs | 300 | diastolic phase | systolic phase | None | Angina management |
Alvarez et al. (2015) | SC | Foot, ankle, calf | 120 | 4 | 16 | Mild to moderate pain | PAD, CLI |
Amanatullah et al. (2020) | IPC | Calf | 45–73 | 1–11 | 60 | None | VTE |
Asano et al. (2001) | IPC | Foot | 130 | 1 | 19 | None | Pulmonary embolism |
Beck et al. (2015) | EECP | Calves, lower thighs, upper thighs / buttocks | 300 | diastolic phase | systolic phase | None | left ventricular dysfunction |
Ben-Galim et al. (2004) | IPC | Calf | 50 | 6 | - | None | DVT |
Berliner et al. (2018) | SC, IPC | Calf | 45–52 | 6–8 | 36–56 | None | VTE |
Berni et al. (2009) | SC | Calf, foot | 120 | 3 | - | Mild calf pain | IC |
Braithwaite et al. (2016) | IPC | Foot | 130 | 6 | 54 | DVT, dorsal foot ulcer, skin maceration | VTE |
Breu et al. (2014) | SC, IPC | Calf, foot | 120 | 17 | 2–3 | Adverse events | PAD |
Broderick et al. (2010) | IPC | Foot | 200 | 3 | - | None | Venous blood flow enhancement |
Casey et al. (2008) | EECP | Calves, lower thigh, upper thigh | 300 | diastolic phase | systolic phase | None | Angina pectoris with CAD |
Chang et al. (2012) | SC, IPC | Foot, calf | 120–140 | 1 | 15 | None | PAD |
Charles et al. (2013) | IPC | Foot | 282 | 2 | - | None | VTE |
Choi et al. (2014) | SC | Leg | 40–45 | 11–12 | 28 | None | Thromboprophylaxis |
Cohen et al. (2007) | EECP | Calves, thighs | 80–300 | diastolic phase | systolic phase | None | Acute coronary syndrome & CS |
Colwell et al. (2010) | IPC | Calf | 50 | 8 | 36–56 | None | DVT prophylaxis |
de Haro et al. (2010) | IPC | Calf | 65 | 3 | - | None | PAD |
Delis et al. (2000) [44] | IPC | Foot, calf | 60–140 | 4 | - | None | Venous emptying optimization |
Delis et al. (2000) [48] | IPC | Foot, calf | 120 | 4 | 16 | None | Peripheral vascular disease, IC |
Delis et al. (2000) [49] | IPC | Foot | 180 | 3 | 17 | None | Peripheral vascular disease, IC |
Delis et al. (2000) [50] | IPC | Foot, calf | 120–180 | 3 | - | None | DVT prophylaxis |
Delis et al. (2001) | IPC | Calf / thigh | 120 | 4 | 16 | None | Arterial flow enhancement |
Delis et al. (2002) | IPC | Foot, calf | 120 | 4 | 16 | None | Skin blood perfusion enhancement |
Delis et al. (2005) | IPC | Foot, calf | 120 | 4 | 16 | None | Arterial claudication enhancement |
Dietz et al. (2020) | SC | Calf | 50 | 8 | 36–56 | DVT, PE, blister formation | DVT |
Eisele et al. (2007) | SC | Calf | 45–52 | 6 | - | None | DVT prophylaxis |
Feldman et al. (2006) | EECP | Calves, thighs, buttocks | 300 | diastolic phase | systolic phase | None | CHF |
Ginzburg et al. (2003) | IPC | Calf | 40 | 12 | 48 | DVT, PE, bleeding | DVT prophylaxis |
Grieveson et al. (2003) | IPC | Lower limbs | 30–40 | 15 | 10 | Pain, discomfort, edema, cramp | Venous insufficiency |
Iwama et al. (2000) | IPC | Calf | 40 | 10 | 50 | None | DVT |
Iwama et al. (2004) | SC | Calf | 60 | 10–20 | 50 | None | DVT |
Jawad et al. (2014) | IPC | Calf, peroneal nerve region | 40 | 12–13 | 47–48 | None | DVT |
Kappa-Markovi et al. (2021) | IPC | Leg | 40 | 15 | - | None | Varicose vein surgery |
Kim et al. (2022) | IPC | Leg | 40–100 | 3–6 | 3–7 | Discomfort | Lymphedema |
Kitayama et al. (2017) | SC | Lower limb | 45–90 | 30 | 20 | Discomfort | Lymph drainage |
Kohro et al. (2002) | SC, IPC | Leg | 45–130 | 3–12 | - | None | DVT prophylaxis |
Kohro et al. (2003) | SC | Leg | 45–130 | 12 | - | None | DVT prophylaxis |
Kohro et al. (2005) | IPC | Leg, soles | 130 | 3 | - | None | DVT prophylaxis |
Koo et al. (2014) | SC | Leg | 40–45 | 12 | 48 | DVT | DVT prophylaxis |
Kozdağ et al. (2012) | EECP | Calves, thighs, buttocks | 280–300 | diastolic phase | systolic phase | None | CHF |
Kurtoglu et al. (2005) | IPC | Calf | 40 | 90 | 30 | PE, leg edema | VTE |
Labropoulos et al. (2005) | IPC | Calf, foot | 120 | 3 | - | Severe pain, popliteal vein reflux, discomfort | Critical limb ischemia |
Li et al. (2024) | IPC | Lower limbs | 40–60 | 15 | - | None | DVT prophylaxis |
Loh et al. (2006) | EECP | Calves, thighs, buttocks | 260–300 | diastolic phase | systolic phase | Leg pain, superficial ecchymosis, cellulitis | Chronic stable refractory angina |
Mayrovitz et al. (2007) | SC | Forearm | 45 | 30 | - | None | Lymphedema |
Meisinger et al. (2017) | SC | Calf | 40 | 12 | 48 | None | Lymphangiography |
Morris et al. (2002) | IPC | Thigh, calf | 60 | 10 | 50 | None | PAD |
Morris et al. (2004) | IPC | Thigh, calf | 60 | 10–60 | 50–60 | None | PAD |
Murakami et al. (2003) | SC, IPC | Calf | 50 | 8.0–11.0 | 52–60 | None | DVT prevention |
Nakanishi et al. (2016) | IPC | Thigh | 50 | 10 | 50 | None | DVT prophylaxis |
Nandwana et al. (2019) | IPC | Arm | 30–45 | 12 | 48 | None | Muscle tissue oxygenation |
Ogawa et al. (2005) | SC | Foot, calf | 80 | 6 | - | PE, mild calf pain, sleeplessness | DVT |
Patterson et al. (2013) | SC | Thigh, calf | 45–30 | 11 | 60 | None | VTE prophylaxis |
Pawlaczyk et al. (2015) | IPC | Foot | 50–72 | 4 | 15 | None | Chronic leg ischemia |
Pitto et al. (2008) | IPC | Foot | 130 | 1 | - | DVT, PE, minor bleeding, discomfort | DVT prophylaxis |
Praxitelous et al. (2018) | IPC | Foot, calf | 40–130 | 1.0–11.0 | 20–49 | None | Lower limb hemodynamics |
Rampengan et al. (2015) | EECP | Calves, lower thigh, upper thigh | 300 | diastolic phase | systolic phase | Cardiovascular events | CHF |
Rifkind et al. (2014) | IPC | Foot, calf | 120 | 4 | 16 | Superficial ecchymosis | Systemic vascular and endothelial function |
Rithalia et al. (2002) | IPC | Leg | 6–124 | 12–50 | 45–60 | None | DVT, edema, venous ulcer |
Sanal-Toprak et al. (2019) | IPC | Arm | 50–80 | 60 | 25 | Cellulitis | Breast cancer-related lymphedema |
Schwenk et al. (2000) | SC | Thigh | 40 | 11 | 60 | None | DVT |
Sheldon et al. (2012) | IPC | Foot, calf | 120 | 2–3 | 3–17 | DVT, discomfort | PAD |
te Slaa et al. (2011) | IPC | Foot | 130 | 0.4 | - | Local skin damage | Postoperative edema management |
Stys et al. (2002) | EECP | Calves, thighs, buttocks | 225–275 | diastolic phase | systolic phase | None | Chronic stable angina |
Tartaglia et al. (2003) | EECP | Calves, lower thighs, upper thighs / buttocks | 250–300 | diastolic phase | systolic phase | None | Chronic stable angina |
Urano et al. (2001) | EECP | Calves, thighs, buttocks | 300 | diastolic phase | systolic phase | Contact dermatitis | coronary artery disease |
Williams et al. (2014) | IPC | Calf, ankle | 45 | 11 | - | Discomfort | Circulatory improvement |
Zaleska et al. (2013) | IPC | Leg | 50–120 | 50 | 50 | None | LLL |
Zaleska et al. (2014) | IPC | Leg | 120 | 50 | 50 | None | LLL |
Zaleska et al. (2015) | IPC | Leg | 120 | 50 | 50 | None | LLL |
Zhou et al. (2023) | IPC | Feet, Calf, thigh | 80–140 | 5–15 | - | None | DVT prevention |
| CHF – Chronic heart failure, CLI – Critical limb ischemia, DVT – Deep vein thrombosis, EECP – External enhanced counter pulsation, IC – Intermittent claudication, IPC – Intermittent pneumatic compression, LLL – Lower limb lymphedema, PAD – Peripheral arterial disease, PE – Pulmonary embolism, SC – Sequential compression, VTE – Venous thromboembolism |
Table 2
Summary of included surgical studies utilizing pneumatic tourniquet systems
Author | Device type | Device location | Cuff pressure (mm Hg) | Duration (minutes) | Complications | Therapeutic action | |
|---|
Ajwani et al. (2012) | Tourniquet | Thigh | 300 | 90–110 | None | TKA | |
Alexandersson et al. (2018) | Tourniquet | Thigh | 300 | ~ 99 | None | TKA | |
Bae et al. (2023) | Tourniquet | Upper arm/thigh | 200–300 | < 120 | Increased postoperative pain | Ortho-limb surgery | |
Besir et al. (2019) | Tourniquet | Thigh | 180–221 | 70–90 | Increased intracranial pressure | Orthopedic lower-extremity surgery | |
Binabdrazak et al. (2014) | Tourniquet | Thigh | 300 | 72 | DVT, PE | TKA | |
Boiko et al. (2004) | Tourniquet | Upper arm | 250–350 | 14 | None | Hand surgery | |
Brix et al. (2022) | Tourniquet | Thigh | 250 | 5–21 | None | Transfemoral amputation | |
Chaiyakit et al. (2024) | Tourniquet | Thigh | 250 | 60–70 | Wound-related | TKA | |
Choksy et al. (2006) | Tourniquet | Thigh | 120–150 | 75 | Hematoma | Transtibial amputation | |
Cousins et al. (2015) | Tourniquet | Upper arm | 250 | 8–10 | Bleeding, pain | Carpal tunnel decompression | |
de Souza et al. (2016) | Tourniquet | Thigh | 350, SBP + 100 | 110–118 | Higher systemic inflammation, muscle injury | TKA | |
Drosos et al. (2013) | Tourniquet | Upper limb | SBP + 100 | 10 | None | Carpal Tunnel Surgery | |
Edwards et al. (2000) | Tourniquet | Arm, forearm | 250 | 20 | Pain | Hand surgery | |
Girardis et al. (2000) | Tourniquet | Thigh | 350 | 75–108 | Hemodynamic instability, metabolic disturbances | Knee ligament surgery | |
Huang et al. (2014) [59] | Tourniquet | Thigh | 280–300 | 107–112 | DVT, wound, pain | TKA | |
Huang et al. (2014) [60] | Tourniquet | Thigh | SBP + 100 | 11–88 | Muscle damage, inflammatory response, wound infection | TKA | |
Kadoi et al. (2009) | Tourniquet | Thigh | 450 | 90 | Increased intracranial pressure, acute metabolic changes | Orthopedic | |
Kanchanathepsak et al. (2023) | Tourniquet | Arm | LOP + (50 to 100), 250 | 14–16 | Pain, discomfort, soft tissue injury, nerve damage | Minor hand surgery | |
Kasem et al. (2019) | Sequential compression | Thigh | 208–283 | 68 | None | Orthopedic | |
Lee et al. (2017) | Tourniquet | Thigh | 143–164 | 67 | Pain, swelling, blisters, skin redness | TKA | |
Leon et al. (2018) | Tourniquet | Thigh | 286–350 | 98–102 | None | TKA | |
Matsui et al. (2021) | Tourniquet | Thigh | 250 | 116–118 | Pain, skin complications | TKA | |
McEwen et al. (2002) | Tourniquet | Calf | 142–250 | 52 | skin complications | Lower limb procedures | |
Mori et al. (2016) | Tourniquet | Thigh | 250 | 64 | DVT | TKA | |
Natesan et al. (2024) | Tourniquet | Thigh | LOP+ (40–80), SBP + 150 | 46 | Pain, swelling | TKA | |
Olivecrona et al. (2012) | Tourniquet | Thigh | 150–300 | 87 | Wound complications, blister, nerve injury, DVT | TKA | |
Olivecrona et al. (2013) | Tourniquet | Thigh | 237 | 81 | Nerve injury | TKA | |
Park et al. (2020) | Tourniquet | Thigh | 215–221 | 50 | DVT, thigh pain | TKA | |
Reilly et al. (2009) | Tourniquet | Thigh | 151–300 | 90 | Pain, delayed functional recovery | Pediatric ACL reconstruction | |
Saenz-Jalón et al. (2017) | Tourniquet | Arm | 300 | 66 | Pain, hyperemia | Upper limb orthopedic procedures | |
Takada et al. (2007) | Tourniquet | Thigh | 350 | 100 | Pain, inflammation | TKA / ACL reconstruction | |
Tetro et al. (2001) | Tourniquet/blood pressure cuff | Thigh | SBP+ (125–150) | 83 | Wound infections, skin blistering, wound hematomas | TKA | |
Tuncali et al. (2003) | Tourniquet | Arm | 118–270 | 116 | None | Upper limb orthopedic surgery | |
Vaishya et al. (2018) | Tourniquet | Thigh | SBP + 150 | 13–44 | Pain, swelling, redness | TKA | |
Van et al. (2008) | Tourniquet | Thigh | 300 | 79 | Pain | Elective knee surgery | |
Wu et al. (2022) | Tourniquet | Thigh | (SBP + 10 mmHg)/KTP; SBP + 100; 300 | 77 | Muscle injury, pain, delayed functional recovery | TKA | |
Yıldırım et al. (2024) | Tourniquet | Thigh | 191–247 | 94–102 | Pain, delayed functional recovery | Foot and ankle surgery | |
Younger et al. (2004) | Tourniquet | Thigh | 202–242 | 100–125 | Cuff pain | Foot and ankle surgery | |
Younger et al. (2011) | Tourniquet | Thigh | 199–260 | 68 | None | Elective foot and ankle operations | |
Zhang et al. (2017) | Tourniquet | Thigh | 316–322 | 91 | DVT, intramuscular vein thrombosis | TKA | |
Zhelun et al. (2024) | Tourniquet | Upper and lower limbs | 180–300 | 70–76 | DVT, delayed wound healing, pain | Orthopedic trauma extremity surgery | |
| ACL – Anterior cruciate ligament, DVT – Deep vein thrombosis, LOP – Limb occlusion pressure, PE – Pulmonary embolism, SBP – Systolic blood pressure, TKA – Total knee arthroplasty |
Table 3
Diagnostic applications of pneumatic compression in clinical studies
Study | Device type | Device location | Cuff pressure (mm Hg) | Therapeutic action |
|---|
Bhamidipaty et al. (2015) | Cuff-based pressure measurement system | Toe | 200 | Peripheral arterial disease diagnosis |
Bilecen et al. (2004) | Standard sphygmomanometer cuff | Calf | 50 | MRI enhancement aid |
| MRI – Magnetic resonance imaging |
Table 4
Summary of studies investigating pneumatic compression for blood flow restriction and sports recovery
Study | Device type | Device location | Cuff pressure (mm Hg) | Duration (minutes) | Complications | Therapeutic action |
|---|
Abbas et al. (2022) | Tourniquet | Upper arm, thigh | 120–180 | - | None | BFR Therapy |
Barbosa et al. (2018) | BFR cuff | Upper arm | 50% of SBP | - | None | Vascular training for AV fistula preparation |
Bentzen et al. (2023) | BFR | Thigh | 60% of LOP | 2 | None | Intermittent claudication management |
Brander et al. (2014) | BFR | Arm | 80%–130% of SBP | - | Discomfort, muscle soreness | Muscle strength and hypertrophy training |
Jønsson et al. (2024) | BFR | Thigh | 40% of AOP | 45 | Discomfort | Muscle rehabilitation in chronic SCI |
| BFR – Blood flow restriction, SBP – Systolic blood pressure, LOP – Limb occlusion pressure, AOP – Arterial occlusion pressure, AV – Arteriovenous, SCI – Spinal cord injury |
Cuff pressure and inflation duration across applications
Cuff pressure and inflation duration are critical parameters that influence the physiological effects and clinical outcomes of pneumatic compression therapy. These parameters vary widely depending on the device type, anatomical location, clinical indication, and intended application (therapeutic, surgical, diagnostic, or sports-related). The following subsections summarize the ranges and distributions of cuff pressures and inflation times reported across the included studies, categorized by their respective application areas.
Therapeutic application
In therapeutic applications, the cuff pressure ranged from 35 mmHg to 300 mmHg, with a median of 87.5 mmHg. Inflation durations varied from 0.4 seconds to 90 seconds, with a median of 8 seconds. The wide range reflects the differences in clinical indications and device protocols. For example, higher pressures were often used in PAD management and EECP therapy. Figure 2 presents box plots summarizing the cuff pressure and inflation time in therapeutic studies.
Surgical application
Surgical applications primarily employed tourniquet systems, with cuff pressures ranging from 150 mmHg to 450 mmHg, with a median of 120 mm Hg. Inflation durations ranged from 9 minutes to 120 minutes with a median of 77 minutes, particularly during orthopedic procedures such as total knee arthroplasty (TKA). Figure 3 illustrates the distribution of cuff pressures and inflation durations in surgical applications.
Diagnostic application
Two studies were classified under diagnostic use. Reported cuff pressures were 50 mmHg and 200 mmHg, while inflation duration was either brief or not explicitly stated. Though limited in number, these studies demonstrate potential roles for pneumatic compression in enhancing diagnostic accuracy.
Sports medicine application
Sports medicine applications involved BFR therapy, aimed at enhancing muscle strength, vascular function, or recovery. These studies used cuff pressure values expressed as a percentage of SBP or LOP, ranging from 40% to 130%. Inflation durations ranged between 2 and 45 minutes.